172 related articles for article (PubMed ID: 34170488)
1. Human cell-based anti-inflammatory effects of rosiglitazone.
Sottili M; Filardi T; Cantini G; Cosmi L; Morano S; Luconi M; Lenzi A; Crescioli C
J Endocrinol Invest; 2022 Jan; 45(1):105-114. PubMed ID: 34170488
[TBL] [Abstract][Full Text] [Related]
2. Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes.
Crescioli C; Cosmi L; Borgogni E; Santarlasci V; Gelmini S; Sottili M; Sarchielli E; Mazzinghi B; Francalanci M; Pezzatini A; Perigli G; Vannelli GB; Annunziato F; Serio M
J Endocrinol; 2007 Oct; 195(1):145-55. PubMed ID: 17911406
[TBL] [Abstract][Full Text] [Related]
3. Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Paolicchi A; Franceschini SS; Salvi M; Ferrannini E
Metabolism; 2011 Feb; 60(2):277-83. PubMed ID: 20206950
[TBL] [Abstract][Full Text] [Related]
4. A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells.
Lombardi A; Cantini G; Piscitelli E; Gelmini S; Francalanci M; Mello T; Ceni E; Varano G; Forti G; Rotondi M; Galli A; Serio M; Luconi M
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):718-24. PubMed ID: 18239149
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of BXL-01-0029, a less hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells.
Sottili M; Cosmi L; Borgogni E; Sarchielli E; Maggi L; Francalanci M; Vannelli GB; Ronconi E; Adorini L; Annunziato F; Romagnani P; Serio M; Crescioli C
Exp Cell Res; 2009 Jan; 315(2):264-73. PubMed ID: 19014933
[TBL] [Abstract][Full Text] [Related]
6. Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells.
Borgogni E; Sarchielli E; Sottili M; Santarlasci V; Cosmi L; Gelmini S; Lombardi A; Cantini G; Perigli G; Luconi M; Vannelli GB; Annunziato F; Adorini L; Serio M; Crescioli C
Endocrinology; 2008 Jul; 149(7):3626-34. PubMed ID: 18372324
[TBL] [Abstract][Full Text] [Related]
7. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
Marx N; Kehrle B; Kohlhammer K; Grüb M; Koenig W; Hombach V; Libby P; Plutzky J
Circ Res; 2002 Apr; 90(6):703-10. PubMed ID: 11934839
[TBL] [Abstract][Full Text] [Related]
8. The antidiabetic agent rosiglitazone upregulates SERCA2 and enhances TNF-alpha- and LPS-induced NF-kappaB-dependent transcription and TNF-alpha-induced IL-6 secretion in ventricular myocytes.
Shah RD; Gonzales F; Golez E; Augustin D; Caudillo S; Abbott A; Morello J; McDonough PM; Paolini PJ; Shubeita HE
Cell Physiol Biochem; 2005; 15(1-4):41-50. PubMed ID: 15665514
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones.
Turner NA; Mughal RS; Warburton P; O'Regan DJ; Ball SG; Porter KE
Cardiovasc Res; 2007 Oct; 76(1):81-90. PubMed ID: 17612514
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients.
Pugazhenthi U; Velmurugan K; Tran A; Mahaffey G; Pugazhenthi S
Diabetologia; 2010 Nov; 53(11):2357-68. PubMed ID: 20635178
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation by IFN‑γ on TNF‑α‑induced chemokine expression in synovial fibroblasts from temporomandibular joint.
Ohta K; Naruse T; Kato H; Ishida Y; Nakagawa T; Ono S; Shigeishi H; Takechi M
Mol Med Rep; 2017 Nov; 16(5):6850-6857. PubMed ID: 28901435
[TBL] [Abstract][Full Text] [Related]
12. TNFα and IFNγ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-κB, and the transcriptional coactivator CREB-binding protein.
Clarke DL; Clifford RL; Jindarat S; Proud D; Pang L; Belvisi M; Knox AJ
J Biol Chem; 2010 Sep; 285(38):29101-10. PubMed ID: 20833730
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-α-activated human fibroblast-like synoviocytes in rheumatoid arthritis.
Chen DP; Wong CK; Leung PC; Fung KP; Lau CB; Lau CP; Li EK; Tam LS; Lam CW
J Ethnopharmacol; 2011 Sep; 137(1):457-68. PubMed ID: 21679760
[TBL] [Abstract][Full Text] [Related]
14. Airway smooth muscle CXCR3 ligand production: regulation by JAK-STAT1 and intracellular Ca²⁺.
Tan X; Alrashdan YA; Alkhouri H; Oliver BG; Armour CL; Hughes JM
Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L790-802. PubMed ID: 23564506
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
[TBL] [Abstract][Full Text] [Related]
16. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Santini E; Franceschini SS; Ferrannini E
J Clin Endocrinol Metab; 2009 May; 94(5):1803-9. PubMed ID: 19276231
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target.
Crescioli C; Sottili M; Bonini P; Cosmi L; Chiarugi P; Romagnani P; Vannelli GB; Colletti M; Isidori AM; Serio M; Lenzi A; Di Luigi L
Eur J Cell Biol; 2012 Feb; 91(2):139-49. PubMed ID: 22176919
[TBL] [Abstract][Full Text] [Related]
18. Effect of SOCS1 overexpression on RPE cell activation by proinflammatory cytokines.
Bazewicz M; Draganova D; Makhoul M; Chtarto A; Elmaleh V; Tenenbaum L; Caspers L; Bruyns C; Willermain F
Neurosci Lett; 2016 Sep; 630():209-215. PubMed ID: 27478014
[TBL] [Abstract][Full Text] [Related]
19. Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer.
Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Di Domenicantonio A; Galleri D; Santarpia L; Basolo F; Ferrannini E; Miccoli P
Cytokine; 2012 Aug; 59(2):218-22. PubMed ID: 22633083
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Rotondi M; Ferrari SM; Fallahi P; Romagnani P; Franceschini SS; Serio M; Ferrannini E
J Clin Endocrinol Metab; 2006 Feb; 91(2):614-20. PubMed ID: 16303841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
